Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wound Care USA, LLC is a medical technology company specializing in advanced wound care solutions through its patented DermaWound product line. Founded by Dr. David M. Dixon, the company develops and commercializes topical formulas designed to treat complex, non-healing wounds such as diabetic foot ulcers, venous stasis ulcers, and pressure sores. Its products utilize biofilm disruption technology and broad-spectrum bactericidal activity to promote rapid healing and reduce the need for invasive procedures like surgical debridement or hyperbaric oxygen therapy. The company serves a global market, providing cost-effective wound management for healthcare facilities and home-based care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wound Care USA.